TABLE II.
Quality indicator | Screening target | Performance |
---|---|---|
Rate (%) of ... | ||
Participation | ≥70 | 54 |
Retention within 30 months of subsequent screen | ≥90 | 82.6 |
Annual screening within 18 months of subsequent screen | NA | 31.8 |
Abnormal call subsequent screens | <5 | 7.2 |
Invasive cancers (n) detected on subsequent screen (per 1000 screens) | >3 | 3.7 |
In situ cancers (n) detected on subsequent screen (per 1000 screens) | NA | 0.8 |
Sensitivity (%) | NA | 84.3 |
Screen-detected invasive tumour size ≤15 mm (%) | >50 | 59.2 |
Node-negative screen-detected invasive cancers (%) | >70 | 76.4 |
Diagnostic interval (%) | ||
First diagnostic assessment within 3 weeks | ≥90 | 66.1 |
Final diagnosis (with no tissue biopsy) within 5 weeks | ≥90 | 79.1 |
Final diagnosis (biopsy) within 7 weeks | ≥90 | 54.9 |
Post-screen invasive cancers (n per 10,000 person–years), 12–24 months | <12 | 12.7 |
Positive predictive value (%), subsequent screen | ≥6 | 6.5 |
Adapted from Canadian Partnership Against Cancer, 201211.